SUTRO BIOPHARMA, INC. (STRO) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $102.48M | +65.2% |
| 2024 | $62.04M | -59.6% |
| 2023 | $153.73M | +126.8% |
| 2022 | $67.77M | +9.5% |
| 2021 | $61.88M | +44.8% |
| 2020 | $42.72M | -0.0% |
| 2019 | $42.74M | +11.2% |
| 2018 | $38.42M | -25.7% |
| 2017 | $51.74M | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $102.48M | +65.2% |
| 2024 | $62.04M | -59.6% |
| 2023 | $153.73M | +126.8% |
| 2022 | $67.77M | +9.5% |
| 2021 | $61.88M | +44.8% |
| 2020 | $42.72M | -0.0% |
| 2019 | $42.74M | +11.2% |
| 2018 | $38.42M | -25.7% |
| 2017 | $51.74M | — |